Optimisation of a triazolopyridine based histone demethylase inhibitor yields a potent and selective KDM2A (FBXL11) inhibitor. England, K. S., Tumber, A., Krojer, T., Scozzafava, G., Ng, S. S., Daniel, M., Szykowska, A., Che, K., von Delft, F., Burgess-Brown, N. A., Kawamura, A., Schofield, C. J., & Brennan, P. E. MEDCHEMCOMM, 5(12):1879-1886, 2014.
doi  bibtex   
@article{ WOS:000345455600013,
Author = {England, Katherine S. and Tumber, Anthony and Krojer, Tobias and
   Scozzafava, Giuseppe and Ng, Stanley S. and Daniel, Michelle and
   Szykowska, Aleksandra and Che, KaHing and von Delft, Frank and
   Burgess-Brown, Nicola A. and Kawamura, Akane and Schofield, Christopher
   J. and Brennan, Paul E.},
Title = {Optimisation of a triazolopyridine based histone demethylase inhibitor
   yields a potent and selective KDM2A (FBXL11) inhibitor},
Journal = {MEDCHEMCOMM},
Year = {2014},
Volume = {5},
Number = {12},
Pages = {1879-1886},
DOI = {10.1039/c4md00291a},
ISSN = {2040-2503},
EISSN = {2040-2511},
ResearcherID-Numbers = {Krojer, Tobias/ABE-3829-2021
   Kawamura, Akane/I-4047-2018
   },
ORCID-Numbers = {Kawamura, Akane/0000-0003-1169-5082
   Krojer, Tobias/0000-0003-0661-0814
   Schofield, Chris/0009-0008-4988-0199
   von Delft, Frank/0000-0003-0378-0017
   Schofield, Christopher/0000-0002-0290-6565
   England, Katherine/0000-0002-4921-7505},
Unique-ID = {WOS:000345455600013},
}

Downloads: 0